Press Releases Eli Lilly and Company Wiener Boerse

Equities

LLYC

US5324571083

End-of-day quote Wiener Boerse Other stock markets 06:00:00 2024-06-05 pm EDT			5-day change	1st Jan Change
770.1 ^EUR	+0.65%		+2.33%	+45.85%

Jun. 07	Jefferies Adjusts Price Target on Eli Lilly to $957 From $925	MT
Jun. 07	US FDA Staff Flags Potential Limited Benefit of Eli Lilly's Alzheimer's Disease Drug	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lilly announces departure of Anat Ashkenazi, chief financial officer	Jun. 05	PR
Eli Lilly and Company - Melissa Seymour to join Lilly as executive vice president of Global Quality	Jun. 05	AQ
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	Jun. 04	AQ
Eli Lilly and : Asco Lilly Oncology Presentation	Jun. 03	PU
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER	May. 31	AQ
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases	May. 29	PR
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	May. 29	AQ
Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference	May. 28	PR
Major manufacturing investment to support API production for tirzepatide	May. 27	AQ
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro	May. 24	AQ
Eli Lilly and : 2015 Global Health Programs Report	May. 24	PU
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines	May. 24	PR
Keysight Technologies, Nordson fall; Eli Lilly, Lam Research rise, Tuesday, 5/21/2024	May. 21	AQ
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	May. 21	AQ
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin	May. 16	PR
Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer	May. 15	PR
Eli Lilly and : Lilly Update on Mounjaro® and Zepbound® (tirzepatide) Compounding Litigation	May. 14	PU
Eli Lilly and : Lilly Statement on FDA Advisory Committee Meeting on Donanemab for Early Symptomatic Alzheimer’s Disease	May. 07	PU
Lilly Declares Second-Quarter 2024 Dividend	May. 06	PR
Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024	Apr. 30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm EDT